✦ LIBER ✦

A Randomized Controlled Trial of Late Conversion from CNI-Based to Sirolimus-Based Immunosuppression Following Renal Transplantation

✍ Scribed by Christopher J. E. Watson; John Firth; Paul F. Williams; John R. Bradley; Nicholas Pritchard; Afzal Chaudhry; Jane C. Smith; Christopher R. Palmer; J. Andrew Bradley

Book ID: 114803638
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 148 KB
Volume: 5
Category: Article
ISSN: 1600-6135
DOI: 10.1111/j.1600-6143.2005.01055.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized controlled trial of late co

A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function

✍ Christopher J.E. Watson; Alexander E.S. Gimson; Graeme J. Alexander; Michael E.D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 1 views

Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin

469: Prospective, randomized, multicente

469: Prospective, randomized, multicenter trial comparing conversion to a CNI-free regimen (MMF & sirolimus) vs. a CNI-reduced, MMF-based immunosuppression to improve renal function in late cardiac transplant recipients

✍ J. Groetzner; U. Schulz; I. Kaczmarek; E. Stegemann; K. Kaiser; M. Voss; T. Witt 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Tubular Toxicity in Sirolimus- and Cyclo

Tubular Toxicity in Sirolimus- and Cyclosporine-Based Transplant Immunosuppression Strategies: An Ancillary Study From a Randomized Controlled Trial

✍ Stefan Franz; Axel Regeniter; Helmut Hopfer; Michael Mihatsch; Michael Dickenman 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 563 KB

Recovery of Renal Function in Heart Tran

Recovery of Renal Function in Heart Transplantation Patients After Conversion From a Calcineurin Inhibitor-Based Therapy to Sirolimus

✍ S.M. Ayub-Ferreira; M.S. Avila; F.S. Feitosa; G.E.C. Souza; S. Mangini; F.G. Mar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Switch to a Sirolimus-Based Immunosuppre

Switch to a Sirolimus-Based Immunosuppression in Long-Term Renal Transplant Recipients: Reduced Rate of (Pre-)Malignancies and Nonmelanoma Skin Cancer in a Prospective, Randomized, Assessor-Blinded, Controlled Clinical Trial

✍ R. Salgo; J. Gossmann; H. Schöfer; H. G. Kachel; J. Kuck; H. Geiger; R. Kaufmann 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 281 KB

The Impact of Conversion From Mycophenol

The Impact of Conversion From Mycophenolate Mofetil to Mycophenolate Sodium Among Renal Transplant Recipients on a Sirolimus-Based Regimen

✍ B.D. Kahan; J. Podbielski; B. Childs 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 132 KB